Skip to main content

Methotrexate Reduces Pain in Hand Osteoarthritis With Synovitis

Medically reviewed by Carmen Pope, BPharm. Last updated on Nov 6, 2023.

By Elana Gotkine HealthDay Reporter

MONDAY, Nov. 6, 2023 -- For patients with hand osteoarthritis and synovitis, methotrexate has a potentially clinically meaningful effect on reducing pain, with no increase in adverse events, according to a study published online Oct. 12 in The Lancet.

Yuanyuan Wang, Ph.D., from Monash University in Melbourne, Australia, and colleagues conducted a randomized, placebo-controlled trial involving participants aged 40 to 75 years with hand osteoarthritis and magnetic resonance imaging-detected synovitis of grade 1 or more. Participants were randomly assigned to receive methotrexate 20 mg or identical placebo once weekly for six months (50 and 47 patients, respectively). The primary outcome was pain reduction in the study hand at six months; 84 and 85 percent of participants in the methotrexate and placebo groups, respectively, provided primary outcome data.

The researchers found that the mean change in visual analogue scale pain at six months was −15.2 mm in the methotrexate group and −7.7 mm in the placebo group, with a mean between-group difference of −9.9 and effect size of 0.45. Adverse events occurred in 62 and 60 percent of participants in the methotrexate and placebo groups, respectively.

"These results support a potential role for methotrexate in the management of hand osteoarthritis with an inflammatory phenotype and highlight the importance of participant selection when testing therapies for hand osteoarthritis," the authors write.

Abstract/Full Text (subscription or payment may be required)

Editorial (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted November 2023

Read this next

Race, Ethnic Disparities Seen in Age-Adjusted Prevalence of Arthritis

WEDNESDAY, July 17, 2024 -- The age-adjusted prevalence of arthritis varies by race and ethnicity, with higher prevalence seen among American Indian/Alaska Native adults...

Osteoarthritis Tied to Higher Risk for Developing Long-Term Multimorbidity

WEDNESDAY, July 17, 2024 -- Individuals with osteoarthritis (OA) face a higher risk for developing severe multimorbidity over 20 years, according to a study published online July...

Worse Outcomes Seen for Severe Bilateral Hip OA in Adult Spinal Deformity

WEDNESDAY, May 15, 2024 -- For patients with adult spinal deformity (ASD), those with severe bilateral hip osteoarthritis (OA) have worse outcomes, according to a study published...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.